Atlas Trials

Validation of a Prognostic Method for Assessing the Risk of Distant Metastasis in Early-stage Breast Cancer

Clinical trial NCT07372261 · ENROLLING_BY_INVITATION

Trial details

NCT number
NCT07372261
Sponsor
Casa Sollievo della Sofferenza IRCCS
Status
ENROLLING_BY_INVITATION
Study type
OBSERVATIONAL
Breast Cancer Early Stage Breast Cancer (Stage 1-3)
Start date
2022-03-10
Primary completion
2026-06-01
Enrollment
1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.